In that regard, TR was able to promote cell death even in myeloid leukemia cells overexpressing BCL-2 and BCL-xL, which is interesting considering that overexpression of antiapoptotic proteins is a resistance mechanism in leukemia treatment [66,67,68]. This evidence concerns the gene BCL2L1 and leukemia.